Rofleponide epimer
Rofleponide epimer is a compound with anti-inflammatory activity. Rofleponide epimer has shown high selectivity in the lungs in experiments. Rofleponide epimer exhibits excellent pharmacological properties by efficiently binding to the rat thymic glucocorticoid receptor. The biotransformation rate of Rofleponide epimer is 10 times higher than that of other known similar drugs, indicating that it has potential application value in inhibiting inflammatory diseases involving mucosa[1].
Product Specifications
CAS Number
144459-71-2
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rofleponide-epimer.html
Smiles
OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@H](C3)O)([C@@]5(C([C@H](C4)F)=CC(CC5)=O)C)F)([H])C[C@@]1([H])O[C@@H](O2)CCC)C)=O
Molecular Formula
C25H34F2O6
Molecular Weight
468.53
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Myotilin (MYOT) (NM_006790) Human Over-expression Lysate
Spectrin Alpha 1 (Erythrocyte Marker) (SPTA1/1832), 1mg/mL
CD79a (B-Cell Marker) (rIGA/764), CF594 conjugate, 0.1mg/mL
Desmoglein-3 (Squamous Cell Marker) (DSG3/2839), CF488A conjugate, 0.1mg/mL
